Evidence map›Paper›PMID 41001156›Full record

ReviewCancer management and research2025

Deep Learning for Cancer Detection Based on Genomic and Imaging Data: A Comprehensive Review.

Xinyu Wang, Can Su

Abstract readReview
In one paragraph

Review in Cancer management and research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Xinyu WangChengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, 610075, People's Republic of China.ORCID 0009-0000-3392-0784
Can SuChengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, 610075, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer is a major global health challenge, and early detection is critical to improving survival rates. Advances in genomics and imaging technologies have made the integration of genomic and imaging data a common practice in cancer detection. Deep learning, especially Convolutional Neural Networks (CNNs), demonstrates substantial potential for early cancer diagnosis by autonomously extracting valuable features from large-scale datasets, thus enhancing early detection accuracy. This review summarizes the progress in deep learning applications for cancer detection using genomic and imaging data. It examines current models, their applications, challenges, and future research directions. Deep learning introduces innovative approaches for precision diagnosis and personalized treatment, facilitating advancements in early cancer screening technologies.

Indexed as

cancer detectiondeep learninggenetic dataimage datareview

Identifiers

PMID41001156
PMCPMC12459622

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.